Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Introduced
Jan 3, 2025
Last Action
Jan 3, 2025
Session
119th Congress
Sponsors
1 primary · 0 co
Passage Probability
2% — Very Low
Introduced in House
Referred to the House Committee on Energy and Commerce.
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
2%
Estimate based on legislative signals
See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.
Upgrade to ProReferred to the House Committee on Energy and Commerce.